Medihoney™

Comvita has a global reputation for premium healthcare products and is committed to the development of innovative natural products based on scientific research. In 2007 Comvita announced the acquisition of Australian company Medihoney in a strategy to become the global leader in medical honey.

Comvita’s Medihoney brand incorporates a range of leading skin and wound care products that are challenging the reliance on synthetic medicines and treatments.

Australia and New Zealand have amongst the world's richest and most unique floral diversity. Some of these plants produce honey with extraordinary therapeutic activity. These clinically significant honeys have exceptional antibacterial activity even against drug resistant bacteria and the products they are used in are revolutionising the management of multiple wound types.

Comvita’s Medihoney product range offers new options in wound and skin care management. Clinical trials are being conducted to further investigate the use of Medihoney for a range of indications including infection control, paediatric burns, leg and foot ulcers, surgical wounds, ophthalmology, haemodialysis exit-sites and control of malodour in chronic wounds.

Medihoney branded products include Derma Cream and Barrier Cream, other medical products include ApiNate wound dressings and Woundcare 18+. 

Please visit Comvita’s Medihoney website for additional product information www.medihoney.com or contact Comvita as follows:

NZ: 0800 504 959
AUST: 1800 466 392
Email: info@comvita.com